Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

Not Applicable

Completed

Conditions: Myofascial Pain Syndrome

Interventions: Drug: trigger point injection

First Posted Date: 2014-11-18

Last Posted Date: 2014-11-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 61

Registration Number: NCT02293083

Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial

Not Applicable

Terminated

Conditions: Locally Advanced Rectal Cancer

Interventions: Radiation: Hyperthermia with concurrent chemo-radiation therapy

First Posted Date: 2014-11-14

Last Posted Date: 2019-11-01

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 14

Registration Number: NCT02290574

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

Phase 2

Conditions: Hepatocellular Carcinoma
Portal Vein Tumor Thrombosis

Interventions: Radiation: Scheduled interval TACE - RT

First Posted Date: 2014-11-14

Last Posted Date: 2014-12-05

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02290977

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas

Phase 2

Completed

Conditions: Non-Hodgkin Lymphoma

Interventions: Drug: Brentuximab vedotin

First Posted Date: 2014-11-02

Last Posted Date: 2018-09-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 33

Registration Number: NCT02280785

Locations: 🇰🇷
Korean Cancer Center Hospital, Seoul, Korea, Republic of
🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of

and more 1 locations

Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery

Completed

Conditions: Fluid Responsiveness
Non Invasive Cardiac Output Monitoring
Prone Position

Interventions: Other: Fluid loading to evaluate fluid responsiveness

First Posted Date: 2014-10-29

Last Posted Date: 2015-07-21

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02277353

Locations: 🇰🇷
Samsung Seoul Hospital, Samsung Medical Center, Seoul, Korea, Republic of

Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage

Phase 1

Completed

Conditions: Mesenchymal Stromal Cells

Interventions: Drug: pneumostem

First Posted Date: 2014-10-24

Last Posted Date: 2017-04-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 9

Registration Number: NCT02274428

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction

Not Applicable

Conditions: Biliary Tract Neoplasms

Interventions: Device: partially covered SEMS
Device: fully covered SEMS

First Posted Date: 2014-10-02

Last Posted Date: 2015-02-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 106

Registration Number: NCT02255669

Locations: 🇰🇷
Samsung Medical Cencer, Seoul, Korea, Republic of

Diffusion-Weighted Magnetic Resonance Imaging

Phase 2

Conditions: Spine Metastasis
Hepatocellular Carcinoma

Interventions: Radiation: External beam radiation therapy

First Posted Date: 2014-09-17

Last Posted Date: 2014-11-07

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 17

Registration Number: NCT02242786

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Whole Breast RT on Prone Position in Korean Women

Phase 2

Conditions: Breast Cancer

Interventions: Radiation: Whole breast RT on prone position

First Posted Date: 2014-09-04

Last Posted Date: 2014-11-07

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 50

Registration Number: NCT02231112

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A Pilot Study of tDCS for Mild Cognitive Impairment

Not Applicable

Conditions: Mild Cognitive Impairment

Interventions: Device: Yband (YDT-201N)
Device: Sham-Yband (YDT-201N)

First Posted Date: 2014-08-28

Last Posted Date: 2014-09-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 20

Registration Number: NCT02227966

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy